DE69912773D1 - Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit. - Google Patents

Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit.

Info

Publication number
DE69912773D1
DE69912773D1 DE69912773T DE69912773T DE69912773D1 DE 69912773 D1 DE69912773 D1 DE 69912773D1 DE 69912773 T DE69912773 T DE 69912773T DE 69912773 T DE69912773 T DE 69912773T DE 69912773 D1 DE69912773 D1 DE 69912773D1
Authority
DE
Germany
Prior art keywords
gabapentin
production process
polymorph
hydrated
producing
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
DE69912773T
Other languages
English (en)
Other versions
DE69912773T2 (de
Inventor
Llado Jordi E- Gerona Bosch
Cruz Rafael Garcia
Grau Elias Molins
Miguel Maria Del Carme Onrubia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medichem SA
Original Assignee
Medichem SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Medichem SA filed Critical Medichem SA
Publication of DE69912773D1 publication Critical patent/DE69912773D1/de
Application granted granted Critical
Publication of DE69912773T2 publication Critical patent/DE69912773T2/de
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C229/02—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton
    • C07C229/28—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino and carboxyl groups bound to acyclic carbon atoms of the same carbon skeleton the carbon skeleton being saturated and containing rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C227/00—Preparation of compounds containing amino and carboxyl groups bound to the same carbon skeleton
    • C07C227/38—Separation; Purification; Stabilisation; Use of additives
    • C07C227/40—Separation; Purification
    • C07C227/42—Crystallisation
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C2601/00—Systems containing only non-condensed rings
    • C07C2601/12—Systems containing only non-condensed rings with a six-membered ring
    • C07C2601/14—The ring being saturated

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Crystallography & Structural Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Neurology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Neurosurgery (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicinal Preparation (AREA)
DE69912773T 1998-05-25 1999-05-10 Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit. Expired - Fee Related DE69912773T2 (de)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
ES009801078A ES2137137B1 (es) 1998-05-25 1998-05-25 Nuevo polimorfo de gabapentina no hidratada, su procedimiento de obtencion y su utilizacion para la obtencion de gabapentina de calidad farmaceutica.
ES9801078 1998-05-25
PCT/ES1999/000127 WO1999061408A1 (es) 1998-05-25 1999-05-10 Polimorfo de gabapentina no hidratada, procedimiento para su obtención y su utilización para la obtención de gabapentina de calidad farmacéutica

Publications (2)

Publication Number Publication Date
DE69912773D1 true DE69912773D1 (de) 2003-12-18
DE69912773T2 DE69912773T2 (de) 2004-09-30

Family

ID=8303893

Family Applications (1)

Application Number Title Priority Date Filing Date
DE69912773T Expired - Fee Related DE69912773T2 (de) 1998-05-25 1999-05-10 Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit.

Country Status (9)

Country Link
US (1) US6521787B1 (de)
EP (1) EP1083164B1 (de)
AU (1) AU3710699A (de)
CA (1) CA2333408A1 (de)
DE (1) DE69912773T2 (de)
ES (1) ES2137137B1 (de)
HU (1) HUP0102104A3 (de)
IL (1) IL139817A (de)
WO (1) WO1999061408A1 (de)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1169060B1 (de) 1999-04-09 2005-08-31 Euro-Celtique S.A. Natrium kanalblocker zusammensetzungen und deren verwendung
ES2164527B1 (es) * 1999-04-26 2003-04-01 Medichen S A Procedimiento de obtencion de gabapentina de calidad farmaceutica.
PT1423168E (pt) 2001-09-03 2006-05-31 Newron Pharm Spa Composicao farmaceutica que compreende gabapentina ou um seu analogo e uma x-aminoamida e a sua utilizacao como analgesico
US6800782B2 (en) 2001-10-09 2004-10-05 Warner-Lambert Co. Anhydrous crystalline forms of gabapentin
ITMI20022071A1 (it) * 2002-10-01 2004-04-02 Erregierre Spa Processo di sintesi dell'acido 1-(aminometil)cicloesanacetico cloridato.
GB2413556B (en) * 2002-11-12 2007-03-14 Tianjin Kinsly Pharmaceutical A new crystal form of adefovir dipivoxil and its composition
WO2004106281A1 (en) * 2003-05-30 2004-12-09 Ranbaxy Laboratories Limited Crystalline gabapentin
US7169812B2 (en) * 2003-07-01 2007-01-30 Medtronic, Inc. Process for producing injectable gabapentin compositions
US20050187295A1 (en) * 2004-02-19 2005-08-25 Surendra Kalyan Processes for the preparation of gabapentin
US20110224435A1 (en) * 2007-08-07 2011-09-15 Ranbaxy Laboratories Limited Process for preparation of amorphous lopinavir
WO2010091257A1 (en) * 2009-02-06 2010-08-12 Bach Pharma, Inc. Pharmaceutical grade phthalazinediones, process for their preparation and pharmaceutical compositions containing them
JP6283663B2 (ja) 2012-05-17 2018-02-21 ジェネンテック， インコーポレイテッド Ａｋｔを阻害するピリミジニルシクロペンタン化合物の非晶質形態、組成物およびその方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4087544A (en) * 1974-12-21 1978-05-02 Warner-Lambert Company Treatment of cranial dysfunctions using novel cyclic amino acids
DE2460891C2 (de) * 1974-12-21 1982-09-23 Gödecke AG, 1000 Berlin 1-Aminomethyl-1-cycloalkanessigsäuren und deren Ester, Verfahren zu deren Herstellung und diese Verbindungen enthaltende Arzneimittel
US4960931A (en) * 1988-05-02 1990-10-02 Warner-Lambert Company Gabapentin mohohydrate and a process for producing the same
US4894476A (en) 1988-05-02 1990-01-16 Warner-Lambert Company Gabapentin monohydrate and a process for producing the same
DE3928184A1 (de) * 1989-08-25 1991-02-28 Goedecke Ag Verfahren zur herstellung von cyclischen aminosaeurederivaten sowie zwischenprodukte
IL119890A (en) * 1996-12-24 2002-03-10 Teva Pharma Gabapentin form iii and preparation of gabapentin form ii

Also Published As

Publication number Publication date
HUP0102104A2 (hu) 2001-11-28
EP1083164B1 (de) 2003-11-12
HUP0102104A3 (en) 2002-11-28
IL139817A (en) 2005-11-20
ES2137137B1 (es) 2000-08-16
AU3710699A (en) 1999-12-13
EP1083164A1 (de) 2001-03-14
WO1999061408A1 (es) 1999-12-02
DE69912773T2 (de) 2004-09-30
US6521787B1 (en) 2003-02-18
CA2333408A1 (en) 1999-12-02
IL139817A0 (en) 2002-02-10
ES2137137A1 (es) 1999-12-01

Similar Documents

Publication Publication Date Title
ATE313317T1 (de) Herstellung von therapeutischem mikroschaum
ATE418547T1 (de) Zwischenprodukte zur herstellung von anti- thrombotischen 4h-cyclopenta-1,3-dioxol-derivaten
DE60006298D1 (de) Verfahren zur Herstellung von Kohlendioxid
DE69934234D1 (de) Verfahren zur herstellung von masa-mehle
DE69635405D1 (de) Prozess zur herstellung bestimmter aza-zyklohexapeptide
ATE304442T1 (de) Anlage zur gleichzeitigen herstellung von verschiedenartigen reifen
ATE236918T1 (de) Aromatische amide, ihrer verfahren zur herstellung ung verwendung als arzneimitteln
DE69938535D1 (de) Dampfphasenprozess zur Herstellung von Aluminid
DE69912773D1 (de) Nicht hydratisiertes gabapentin polymorph, herstellungsprozess und verwendung zur herstellung von gabapentin pharmazeutischer reinheit.
DE60323994D1 (de) Verfahren zur herstellung von 2-chlor-1,1,1,2,3,3,3-heptafluorpropan, hexafluorpropen und 1,1,1,2,3,3,3-heptafluorpropan
DE60201498D1 (de) Verbesserter prozess zur herstellung von carbapenemen
DE69502384D1 (de) Prozess zur herstellung von polyarylenetherketonen
ATE327257T1 (de) Fester, stabiler und konzentrierter biologisch verdaulicher komplex von orthokieselsäure und prozess zur dessen herstellung
DE69509705D1 (de) Vorläufersubstanz zur Herstellung von SiO2TiO2
DE69809828D1 (de) Verfahren zur Herstellung von Nudeln
DE69527163D1 (de) Verfahren zur Herstellung von aromatischen Polycarbonaten
ATE400560T1 (de) Verfahren zur herstellung von 10,11 dihydro 10 hydroxy 5h-dibenz/b,f/azepin-5-carbonsäureamid und 10,11 dihydro 10 oxo-5h-dibenz/b,f/azepin-5 carbonsäureamid
DE69617453D1 (de) Neuartiger photokatalysator, seine herstellung und methode zur wasserstoffproduktion mit demselben
DE60219188D1 (de) Verfahren zur herstellung von olefinen.
DE69725580D1 (de) Prozess zur herstellung von aza zyclohexapeptide
DE60219800D1 (de) Verfahren zur herstellung von cilastatin
DE59805764D1 (de) Verfahren zur selektiven Herstellung von racemischen ansa-Metallocenkomplexen
DE60220554D1 (de) Mikrowelleninduzierter prozess zur herstellung von substituierten 4-vinylphenolen
DE60239085D1 (de) Prozess zur Herstellung von E-Caprolactam
AU2002325942A1 (en) Process for the production of l-amino acids using coryneform bacteria

Legal Events

Date Code Title Description
8364 No opposition during term of opposition
8339 Ceased/non-payment of the annual fee